Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28339098

Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2017 Jul 15
First author
Stark DP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Stark DP
      type
      Author
    2. name
      Cook A
      type
      Author
    3. name
      Brown JM
      type
      Author
    4. name
      Brundage MD
      type
      Author
    5. name
      Embleton AC
      type
      Author
    6. name
      Kaplan RS
      type
      Author
    7. name
      Raja FA
      type
      Author
    8. name
      Swart AMW
      type
      Author
    9. name
      Velikova G
      type
      Author
    10. name
      Qian W
      type
      Author
    11. name
      Ledermann JA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Stark DP
      type
      Author
    2. name
      Cook A
      type
      Author
    3. name
      Brown JM
      type
      Author
    4. name
      Brundage MD
      type
      Author
    5. name
      Embleton AC
      type
      Author
    6. name
      Kaplan RS
      type
      Author
    7. name
      Raja FA
      type
      Author
    8. name
      Swart AMW
      type
      Author
    9. name
      Velikova G
      type
      Author
    10. name
      Qian W
      type
      Author
    11. name
      Ledermann JA
      type
      Author
    bibliography ids
    1. nci-bib-bec82959854ed1e51406708d
    book metadata
    content sha256
    6970a1b6061328e38d1f581a863662e24ce3dde3689fcc7d45d43940a2c3f597
    document type
    citation
    dois
    1. 10.1002/cncr.30657
    electronic publication date
    display
    2017 Mar 24
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28339098
    immutable id
    pubmed:28339098@6970a1b6061328e38d1f581a863662e24ce3dde3689fcc7d45d43940a2c3f597
    journal
    abbreviation
    Cancer
    issn electronic
    1097-0142
    issn print
    0008-543X
    issue
    14
    name
    Cancer
    nlm unique id
    0374236
    pages
    2752-2761
    volume
    123
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28339098
      provenance
      batch id
      7a1288ac8bb5f9826304
      provider
      NCBI PubMed ESummary
      record sha256
      68863b186f077639d5f8de160f03df2c35d5805558ad1ea1f4cac14982d8e51f
      response sha256
      0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
      retrieved at
      2026-09-09T23:47:23.138359+00:00
      publication date
      display
      2017 Jul 15
      precision
      day
      year
      2017
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28339098/
      title
      Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.

      Preserved source evidence · Not medical advice